How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Keratoprosthesis Market
- By Type of Keratoprosthesis: Boston Keratoprosthesis (Boston KPro), Osteo-Odonto-Keratoprosthesis (OOKP), AlphaCor Keratoprosthesis, KeraKlear Keratoprosthesis, Lux KPro
- By Material: PMMA (Polymethyl Methacrylate), Titanium, Hydrogel, Biocompatible Polymers
- By Indication: Severe Corneal Opacity, Multiple Failed Corneal Transplants, Chemical or Thermal Burns, Autoimmune Corneal Diseases, Congenital Corneal Opacities
- By End-User: Hospitals, Specialized Eye Clinics, Ambulatory Surgical Centers
- By Surgical Technique: Single-Stage Implantation, Two-Stage Implantation
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Boston Keratoprosthesis (Boston KPro) leads By Type of Keratoprosthesis at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.176 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.184 →
Full report · locked preview
Everything inside the Keratoprosthesis Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Type of Keratoprosthesis 5
Material 4
Indication 5
End-User 3
Surgical Technique 2
Companies profiled
AcuFocus Inc.
CorNeat Vision
KeraMed Inc.
OsteoMed Inc.
CorNeat KPro
CorNeat Vision Ltd.
Avedro Inc.
EyeYon Medical Ltd.
Domilens
EpiSmart
AcuFocus
KeraMed
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →AcuFocus Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →CorNeat Vision
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →KeraMed Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →OsteoMed Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →CorNeat KPro
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →CorNeat Vision Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Avedro Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →EyeYon Medical Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Domilens
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →EpiSmart
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →AcuFocus
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →KeraMed
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →OsteoMed
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →EyeYon Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$965.0M by 2033 · 6.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Boston Keratoprosthesis (Boston KPro)53.6
- Osteo-Odonto-Keratoprosthesis (OOKP)11.1
- AlphaCor Keratoprosthesis15.0
- KeraKlear Keratoprosthesis8.3
- Lux KPro12.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$199.1M → $302.6M · 5.4%
Europe$138.8M → $235.5M · 6.8%
Asia Pacific$126.7M → $183.4M · 4.7%
Latin America$78.4M → $131.1M · 6.6%
Middle East and Africa$60.3M → $88.6M · 4.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.992026
6.012027
6.022028
6.042029
6.042030
6.062031
6.062032
6.092033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- AcuFocus Inc.18.3
- CorNeat Vision23.8
- KeraMed Inc.6.0
- OsteoMed Inc.8.5
- CorNeat KPro5.6
- CorNeat Vision Ltd.9.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Type of Keratoprosthesis12.9%
Material20.2%
Indication30.0%
End-User9.7%
Surgical Technique27.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.2
- Europe25.0
- Asia Pacific19.5
- Latin America13.9
- Middle East and Africa9.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| AcuFocus Inc. | 92 | 93 | 92 | 84 | 74 | 76 | 85 |
| CorNeat Vision | 78 | 88 | 92 | 74 | 71 | 87 | 82 |
| KeraMed Inc. | 82 | 72 | 74 | 78 | 86 | 65 | 76 |
| OsteoMed Inc. | 72 | 60 | 58 | 68 | 64 | 68 | 65 |
| CorNeat KPro | 53 | 54 | 63 | 75 | 55 | 67 | 61 |
| CorNeat Vision Ltd. | 65 | 62 | 68 | 53 | 64 | 67 | 63 |
| Avedro Inc. | 42 | 52 | 64 | 57 | 59 | 51 | 54 |
| EyeYon Medical Ltd. | 47 | 36 | 43 | 42 | 60 | 45 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- AcuFocus Inc.
- CorNeat Vision
- KeraMed Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| AcuFocus Inc. | ✓ | ✓ | ✓ | ✓ | ◐ | ◐ |
| CorNeat Vision | ◐ | ◐ | ✓ | ◐ | ✓ | ◐ |
| KeraMed Inc. | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| OsteoMed Inc. | ✓ | ◐ | − | − | ◐ | ✓ |
| CorNeat KPro | ◐ | − | ◐ | ✓ | ◐ | ◐ |
| CorNeat Vision Ltd. | ✓ | ◐ | − | ◐ | − | ✓ |
| Avedro Inc. | − | ◐ | ✓ | − | − | ◐ |
| EyeYon Medical Ltd. | − | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1AcuFocus Inc.85
2CorNeat Vision82
3KeraMed Inc.76
4OsteoMed Inc.65
5CorNeat Vision Ltd.63
6CorNeat KPro61
7Avedro Inc.54
8EyeYon Medical Ltd.46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
AcuFocus Inc.CorNeat Vision
Challenger1
Strong scale, closing on the leaders.
KeraMed Inc.
Contender3
Focused players with pockets of strength.
OsteoMed Inc.CorNeat KProCorNeat Vision Ltd.
Niche2
Specialists in a single segment or region.
Avedro Inc.EyeYon Medical Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Type of Keratoprosthesis in North America, then scale across Keratoprosthesis Market — a $559M beachhead inside a $8.26B market.
Beachhead (SOM)$559Mobtainable near-term
Serviceable (SAM)$3.31Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Boston Keratoprosthesis (Boston KPro)
Best fit — highest urgency & budget in Type of Keratoprosthesis.
Economic buyer78 fit
Osteo-Odonto-Keratoprosthesis (OOKP)
Strong fit — clear ROI and a fast path to value.
End user65 fit
AlphaCor Keratoprosthesis
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Type of Keratoprosthesis in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Indication
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel28%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Type of Keratoprosthesis leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Keratoprosthesis Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified22%
Evaluation12%
Closed-won6%
$17.2KCAC
$94KLTV
5.5:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Keratoprosthesis Market is a resilient opportunity — $1.39B by 2033, compounding at 4.4%.
TAM · 2025$982Mtoday
TAM · 2033$1.39Bforecast
CAGR4.4%2027–2033
Cumulative$10.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.39BTotal addressable market
SAM$486MServiceable available market
SOM$84MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.4% CAGR
Demand compounds through 2033, outpacing GDP across Type of Keratoprosthesis.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Type of Keratoprosthesis moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.39BLarge & growingTAM by 2033 at 4.4% CAGR
$486MServiceable nowreachable with today’s model
$84MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.08BBear2.9% CAGR
$1.39BBase4.4% CAGR
$1.78BBull5.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Keratoprosthesis Market — a $3.41B market by 2033. Plan: grow share from 6.9% to 14.2%.
Market size · 2033$3.41Btotal addressable
Market CAGR10.3%2027–2033
Target share14.2%from 6.9% today
Revenue ambition$484Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.9% | 14.2% | At risk |
| Revenue | $248M | $484M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 28.7% | 38.9% | Behind |
| Customer retention | 90.0% | 97.0% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Type of Keratoprosthesis
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material capability
A defensible second engine — invest in Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Type of Keratoprosthesis share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $57M capacity & capability investment
- Greenlight bolt-on M&A in Material
- Authorise North America expansion plan
- Fund R&D program for Type of Keratoprosthesis leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskAt risk
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Keratoprosthesis Market conversation — a $7.68B market you can size, segment and defend in minutes.
Market size · 2033$7.68Btotal opportunity
Growth8.2%CAGR to 2033
Addressable buyers1,499+accounts in scope
Typical ROI6.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Type of Keratoprosthesis
Goal Grow share in Type of Keratoprosthesis
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.3×return on cost, year one
< 3 mopayback period
$46K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
AcuFocus Inc.CorNeat VisionKeraMed Inc.OsteoMed Inc.CorNeat KProCorNeat Vision Ltd.Avedro Inc.EyeYon Medical Ltd.+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Keratoprosthesis Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Keratoprosthesis Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Kerosene for Jet Market
Market size, share, segmentation and regional forecast.
$661M market · 2025 base year
View reportKerosene Oil Market
Market size, share, segmentation and regional forecast.
$651M market · 2025 base year
View reportKerosene Stove Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportKetene Market
Market size, share, segmentation and regional forecast.
$384M market · 2025 base year
View reportKetjen Black Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportKeto Low-Calorie Meals Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportKeto Peanut Butter Snacks Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportKeto Snack Foods Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportKetoleucine calcium salt dihydrate CAS 51828-95-6 Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportKetone Aldehyde Resin Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportKetone Fungicides Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportKetone Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.